{"id":"W2104748005","doi":"10.1200/jco.2009.24.3030","title":"Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial","year":2009,"lang":"en","type":"letter","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Gefitinib; Docetaxel; Medicine; Lung cancer; Oncology; Internal medicine; Biomarker; Hazard ratio; Epidermal growth factor receptor; KRAS; Cancer; Confidence interval; Biology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002496931,0.000352216,0.004883724,0.0001613636,0.00002962682,0.00002010165,0.0005057906,0.0008673124,0.00008355481],"category_scores_gemma":[0.001545905,0.0001725228,0.0005412506,0.0001402265,0.0004005752,0.0000910666,0.00009693721,0.002737694,6.251437e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002005285,"about_ca_system_score_gemma":0.002525939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001042989,"about_ca_topic_score_gemma":0.0005115237,"domain_scores_codex":[0.9936299,0.001090453,0.004178382,0.0004306356,0.0003852832,0.0002852864],"domain_scores_gemma":[0.9891506,0.005244972,0.00447746,0.0006299021,0.0002997381,0.0001973491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8106689,0.003145466,0.01950856,0.0001520699,0.007168279,0.005506893,0.0003856138,0.00001201393,0.00001181739,0.000001423305,0.1440438,0.009395188],"study_design_scores_gemma":[0.9193437,0.01050053,0.001722064,0.001002279,0.02014992,0.00008685639,0.00004527777,0.0001960388,0.00001008002,0.00001925697,0.0467663,0.0001577679],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8127968,0.005029476,0.0001105621,0.17714,0.001008063,0.003065058,0.000292911,0.000007282604,0.0005498023],"genre_scores_gemma":[0.6755992,0.01404104,0.002142958,0.2910148,0.0141834,0.0002129334,0.001562406,0.0001464513,0.001096768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1371976,"threshold_uncertainty_score":0.999563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1212243943653459,"score_gpt":0.490069456183446,"score_spread":0.3688450618181001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}